GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qurient Co Ltd (XKRX:115180) » Definitions » Price-to-Funds-From-Operations

Qurient Co (XKRX:115180) Price-to-Funds-From-Operations : (As of May. 04, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Qurient Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Qurient Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
C-dong 8th Floor, 242, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 13487
Qurient Co Ltd is a South Korea based biotech company. It is engaged in network research & development business model, integrating research and drug development programs with a new mechanism. Its pipeline products include Q301 for the treatment of atopic dermatitis; Q203 treats MDR/XDR/TDR TB, and Q701 is a drug-resistant cancer immuno-oncology.